Whitehawk Therapeutics Inc (WHWK)
$2.97-1.66%Close
SELLCRISIS · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $147M
- Beta
- 0.81
- P/E (TTM)
- -2.65
- Short % float
- 13.16%
- Days to cover
- 7.1
- SI change
- -0.6%
- 1W
- -12.90%
- 1M
- -27.38%
- vs SPY 1W
- -12.76%
- vs SPY 1M
- -29.89%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on WHWK?
- LOPJLB’s latest quantitative signal on Whitehawk Therapeutics Inc (WHWK) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is WHWK in?
- Whitehawk Therapeutics Inc (WHWK) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Whitehawk Therapeutics Inc (WHWK) do?
- Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, In…